spacer
spacer

PDBsum entry 4oga

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Hormone receptor/hormone/immune system PDB id
4oga

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
21 a.a.
21 a.a.
118 a.a.
114 a.a.
288 a.a.
15 a.a.
Ligands
NAG-NAG-BMA-MAN
NAG-NAG-BMA-FUC
NAG ×3
PDB id:
4oga
Name: Hormone receptor/hormone/immune system
Title: Insulin in complex with site 1 of the human insulin receptor
Structure: Insulin a chain. Chain: a. Fragment: unp residues 90-110. Synonym: insulin b chain, insulin a chain. Engineered: yes. Insulin b chain. Chain: b. Fragment: unp residues 25-54. Synonym: insulin b chain, insulin a chain.
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: ins. Expressed in: saccharomyces cerevisiae. Expression_system_taxid: 4932. Mus musculus. Mouse. Organism_taxid: 10090.
Resolution:
3.50Å     R-factor:   0.265     R-free:   0.284
Authors: M.C.Lawrence,J.G.Menting
Key ref: J.G.Menting et al. (2014). Protective hinge in insulin opens to enable its receptor engagement. Proc Natl Acad Sci U S A, 111, E3395. PubMed id: 25092300 DOI: 10.1073/pnas.1412897111
Date:
15-Jan-14     Release date:   27-Aug-14    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P01308  (INS_HUMAN) -  Insulin from Homo sapiens
Seq:
Struc:
110 a.a.
21 a.a.
Protein chain
Pfam   ArchSchema ?
P01308  (INS_HUMAN) -  Insulin from Homo sapiens
Seq:
Struc:
110 a.a.
21 a.a.
Protein chain
No UniProt id for this chain
Struc: 118 a.a.
Protein chain
No UniProt id for this chain
Struc: 114 a.a.
Protein chain
Pfam   ArchSchema ?
P06213  (INSR_HUMAN) -  Insulin receptor from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1382 a.a.
288 a.a.*
Protein chain
Pfam   ArchSchema ?
P06213  (INSR_HUMAN) -  Insulin receptor from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1382 a.a.
15 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 3 residue positions (black crosses)

 Enzyme reactions 
   Enzyme class: Chains E, F: E.C.2.7.10.1  - receptor protein-tyrosine kinase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H+
L-tyrosyl-[protein]
+ ATP
= O-phospho-L-tyrosyl-[protein]
Bound ligand (Het Group name = NAG)
matches with 41.38% similarity
+ ADP
+ H(+)
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    Added reference    
 
 
DOI no: 10.1073/pnas.1412897111 Proc Natl Acad Sci U S A 111:E3395 (2014)
PubMed id: 25092300  
 
 
Protective hinge in insulin opens to enable its receptor engagement.
J.G.Menting, Y.Yang, S.J.Chan, N.B.Phillips, B.J.Smith, J.Whittaker, N.P.Wickramasinghe, L.J.Whittaker, V.Pandyarajan, Z.L.Wan, S.P.Yadav, J.M.Carroll, N.Strokes, C.T.Roberts, F.Ismail-Beigi, W.Milewski, D.F.Steiner, V.S.Chauhan, C.W.Ward, M.A.Weiss, M.C.Lawrence.
 
  ABSTRACT  
 
Insulin provides a classical model of a globular protein, yet how the hormone changes conformation to engage its receptor has long been enigmatic. Interest has focused on the C-terminal B-chain segment, critical for protective self-assembly in β cells and receptor binding at target tissues. Insight may be obtained from truncated "microreceptors" that reconstitute the primary hormone-binding site (α-subunit domains L1 and αCT). We demonstrate that, on microreceptor binding, this segment undergoes concerted hinge-like rotation at its B20-B23 β-turn, coupling reorientation of Phe(B24) to a 60° rotation of the B25-B28 β-strand away from the hormone core to lie antiparallel to the receptor's L1-β2 sheet. Opening of this hinge enables conserved nonpolar side chains (Ile(A2), Val(A3), Val(B12), Phe(B24), and Phe(B25)) to engage the receptor. Restraining the hinge by nonstandard mutagenesis preserves native folding but blocks receptor binding, whereas its engineered opening maintains activity at the price of protein instability and nonnative aggregation. Our findings rationalize properties of clinical mutations in the insulin family and provide a previously unidentified foundation for designing therapeutic analogs. We envisage that a switch between free and receptor-bound conformations of insulin evolved as a solution to conflicting structural determinants of biosynthesis and function.
 

 

spacer

spacer